We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS IPROS One of the largest technical database sites in Japan that collects information on.

medicine×マーケットリサーチセンター - List of Manufacturers, Suppliers, Companies and Products

medicine Product List

46~60 item / All 465 items

Displayed results

[Research Material] The Global Market for Halitosis Treatment

Global Market for Halitosis Treatment: Pathological Halitosis, Others, Hospitals, Clinics

This research report (Global Halitosis Treatment Market) investigates and analyzes the current state and future outlook of the global market for halitosis treatment over the next five years. It includes information on the overview of the global halitosis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the halitosis treatment market focus on pathological halitosis and others, while the segments by application target hospitals and clinics. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for halitosis treatment. It also includes the market share of major companies in halitosis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Treatment of Erythropoietic Protoporphyria (EPP)

World Market for the Treatment of Erythropoietic Protoporphyria (EPP): Hormonal Therapy, Adjuvant Therapy, Phototherapy, Hospital Pharmacies, Drugstores, Retail Pharmacies ...

This research report (Global Erythropoietic Protoporphyria (EPP) Treatment) investigates and analyzes the current state and outlook for the global market for the treatment of erythropoietic protoporphyria (EPP) over the next five years. It includes information on the overview of the global erythropoietic protoporphyria (EPP) treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for erythropoietic protoporphyria (EPP) treatment by type include hormone therapy, adjunctive therapy, and phototherapy, while the segments by application target hospital pharmacies, drugstores, retail pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for erythropoietic protoporphyria (EPP) treatment. It also includes the market share of major companies in the erythropoietic protoporphyria (EPP) treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Arginase Deficiency Treatment

Global Market for Arginase Deficiency Treatment: Oral, Injection, Hospital, Drugstore, Others

This research report (Global Arginase Deficiency Treatment Market) investigates and analyzes the current state and outlook for the global market for arginase deficiency treatment over the next five years. It includes information on the overview of the global arginase deficiency treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the arginase deficiency treatment market by type focus on oral and injectable forms, while the segments by application target hospitals, drugstores, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for arginase deficiency treatment. It also includes the market share of major companies in the arginase deficiency treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Zoonotic Disease Treatment

Global Market for Zoonotic Disease Treatment: Viral Hepatitis, Rabies, Relapsing Fever, Tuberculosis, Malaria, Hospitals, Clinics

This research report (Global Zoonotic Disease Treatment Market) investigates and analyzes the current status and outlook for the global market for zoonotic disease treatment over the next five years. It includes information on the overview of the global zoonotic disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the zoonotic disease treatment market focus on viral hepatitis, rabies, relapsing fever, tuberculosis, and malaria, while the segments by application target hospitals and clinics. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for zoonotic disease treatment. It also includes the market share of major companies in zoonotic disease treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Cystic Acne Treatment

World Market for Cystic Acne Treatment: Topical Medications, Laser Treatments, Microdermabrasion, Others, Hospitals, Clinics, Others

This research report (Global Cystic Acne Treatment Market) investigates and analyzes the current status and outlook for the global market for cystic acne treatment over the next five years. It includes information on the overview of the global cystic acne treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the cystic acne treatment market include topical medications, laser treatments, microdermabrasion, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for cystic acne treatment. It also includes the market share of major companies in cystic acne treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Hepatitis Treatment Drugs

World Market for Hepatitis Treatment Drugs: VEMLIDY, EPCLUSA, SOVALDI, INCIVEK, OLYSIO, VICTRELIS, ...

This research report (Global Hepatitis Drugs Market) investigates and analyzes the current state and outlook for the global hepatitis treatment drug market over the next five years. It includes information on the overview of the global hepatitis treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include VEMLIDY, EPCLUSA, SOVALDI, INCIVEK, OLYSIO, VICTRELIS, VIREAD, HEPSERA, BARACLUDE, and TYZEKA, while the segments by application focus on hepatitis A, B, C, D, and E. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for hepatitis treatment drugs. The report also includes the market share of major companies in the hepatitis treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Tourette Syndrome Treatment Drugs

World Market for Tourette Syndrome Treatments: AZD-5213, CPP-115, Dutetrabenazine ER, Ecopipa ...

This research report (Global Tourette Syndrome Drug Market) investigates and analyzes the current state and future outlook of the global market for Tourette syndrome treatment drugs over the next five years. It includes information on the overview of the global Tourette syndrome treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include AZD-5213, CPP-115, Dutetrabenazine ER, Ecopipam Hydrochloride, and Others, while the segments by application focus on research centers, hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Tourette syndrome treatment drugs. The report also includes the market share of major companies in the Tourette syndrome treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Cushing's Syndrome Treatment

World Market for Cushing's Syndrome Treatment: Glucocorticoid Receptor Inhibitors, Somatostatin, Ketoconazole HRA, Others, Hospital Pharmacies, Small ...

This research report (Global Cushing's Syndrome Treatment Market) investigates and analyzes the current status and outlook for the global market for Cushing's syndrome treatment over the next five years. It includes information on the overview of the global Cushing's syndrome treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Cushing's syndrome treatment market include glucocorticoid receptor antagonists, somatostatin, ketoconazole HRA, and others, while the segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Cushing's syndrome treatment. It also includes the market share of major companies in the Cushing's syndrome treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for mRNA Vaccines and Therapeutics

Global Market for mRNA Vaccines and Therapeutics: Infectious Disease Vaccines, Cancer Vaccines, Infectious Diseases, Cancer, Others

This research report (Global mRNA Vaccines & Therapeutics Market) investigates and analyzes the current state and future outlook of the global mRNA vaccine and therapeutic market over the next five years. It includes information on the overview of the global mRNA vaccine and therapeutic market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on infectious disease vaccines and cancer vaccines, while the segments by application target infectious diseases, cancer, and others. The regional segments calculate the market size of mRNA vaccines and therapeutics by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the mRNA vaccine and therapeutic market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Materials] Global Market for Treatment Drugs for Muscular Dystrophy

Global Market for Treatment Drugs for Myotonic Dystrophy: ISIS-DMPKRx, PRO-135, SRT-152, VAL-0411, and others...

This research report (Global Myotonic Dystrophy Drug Market) investigates and analyzes the current state and outlook for the global market for myotonic dystrophy treatments over the next five years. It includes information on the overview of the global myotonic dystrophy drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis, among other details. The market segments by type include ISIS-DMPKRx, PRO-135, SRT-152, VAL-0411, and others, while the segments by application focus on hospitals, clinics, home care, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for myotonic dystrophy treatments. It also includes the market share of major companies in the myotonic dystrophy drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Rare Disease Treatments

Global Market for Rare Disease Treatments: Originator Drugs, Generic Drugs, Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies

This research report (Global Rare Disease Treatment Market) investigates and analyzes the current state of the global market for rare disease treatments and its outlook for the next five years. It includes information on the overview of the global rare disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the rare disease treatment market focus on originator drugs and generic drugs, while the segments by application target hospital pharmacies, specialty pharmacies, and retail pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for rare disease treatments. It also includes the market share of major companies in the rare disease treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Treatments of Nasopharyngeal Cancer

World Market for Oropharyngeal Cancer Treatments: BGBA317, CBT501, Apatinib, APG1387, ARGX110, ATA129, and others...

This research report (Global Nasopharyngeal Cancer Drug Market) investigates and analyzes the current status and outlook for the global market of nasopharyngeal cancer treatments over the next five years. It includes information on the overview of the global nasopharyngeal cancer drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include BGBA317, CBT501, Apatinib, APG1387, ARGX110, ATA129, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are classified into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for nasopharyngeal cancer treatments. It also includes the market share of major companies in the nasopharyngeal cancer drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Epidermolysis Bullosa Treatment Drugs

Global Market for Epidermolysis Bullosa Treatment Drugs: EB-201, FCX-007, ICX-RHY, INM-750, Others, Clinics, Hospitals, Others

This research report (Global Epidermolysis Bullosa Therapeutics Market) investigates and analyzes the current status and future outlook of the global market for epidermolysis bullosa therapeutics over the next five years. It includes information on the overview of the global epidermolysis bullosa therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include EB-201, FCX-007, ICX-RHY, INM-750, and others, while the segments by application focus on clinics, hospitals, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for epidermolysis bullosa therapeutics. It also includes the market share of major companies in the epidermolysis bullosa therapeutics sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Vascular Occlusion Crisis Associated with Sickle Cell Disease Treatments

Global Market for Vascular Occlusion Crisis Associated with Sickle Cell Disease Treatments: SGD-2083, Crizanlizumab, PF-04447943, NVX-50 ...

This research report (Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease) investigates and analyzes the current state and outlook for the global market of vaso-occlusive crises associated with sickle cell disease treatments over the next five years. It includes information on the overview of the global market for vaso-occlusive crises associated with sickle cell disease treatments, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type for vaso-occlusive crises associated with sickle cell disease treatments include SGD-2083, crizanlizumab, PF-04447943, NVX-508, and others, while the segments by application include clinics, hospitals, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for vaso-occlusive crises associated with sickle cell disease treatments. The report also includes the market share of major companies in the vaso-occlusive crises associated with sickle cell disease treatments, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Rare Hematology Treatments

Global Market for Rare Hematology Treatments: Plasma-Derived Factors, Recombinant Factors, Hemophilia A, Hemophilia B, von Willebrand Disease, Others

This research report (Global Rare Hematology Treatment Market) investigates and analyzes the current state and outlook for the global market of rare hematology treatments over the next five years. It includes information on the overview of the global rare hematology treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the rare hematology treatment market focus on plasma-derived factors and recombinant factors, while the segments by application target hemophilia A, hemophilia B, von Willebrand disease, and others. The regional segments calculate the market size for rare hematology treatments by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the rare hematology treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine